다발성골수종 환자에서 Osteopontin의 임상적 의의

키워드

참고문헌 (22)

1. "The role of the bone marrowmicroenvironment in multiple myeloma", 20, pp.1227~1250 (2005)
2. "Human myeloma cells express the bone regulating gene Runx2", Cbfa1and produce osteopontin that is involved in angiogenesis inmultiple myeloma patients, 2005, pp.19, 2166~2176
3. "Angiogenesis in multiple myeloma", 42, pp.1581~1590 (2006)
4. "Mye-loma cell-osteoclast interaction enhances angiogenesis together withbone resorption: a role for vascular endothelial cell growth factorand osteopontin", 13, pp.816~823 (2007)
5. "Osteopontin--a molecular for all seasons", 95, pp.3~13 (2002)
6. "Osteopontin, angiogenesis and mul-tiple myeloma", 19, pp.2203~2205 (2005)
7. "Tumor angiogenesisand metastasis--correlation in invasive breast carcinoma", 324, pp.1~8 (1991)
8. "A high pretreatment serum vas-cular endothelial growth factor concentration is associated with pooroutcome in non-Hodgkin s lymphoma", 90, pp.3167~3172 (1997)
9. "Con-comitant expression of hepatocyte growth factor", scatter factor andthe receptor c-MET in human myeloma cell lines, 1996, pp.271, 24655~24661
10. "Role ofhepatocyte growth factor and its receptor c-met in multiple myeloma", 15, pp.145~153 (1998)
11. "Elevated level of plasma basic fibroblast growth factor in multi-ple myeloma correlates with increased disease activity", 93, pp.459~466 (2002)
12. "Clinical significance of vascular endothelial growth factor andhepatocyte growth factor in multiple myeloma", 116, pp.796~802 (2002)
13. "Angiogenic factors in multiple myeloma: higherlevels in bone marrow than in peripheral blood", 85, pp.800~805 (2000)
14. "Enhanced production of osteopontin in multiple myeloma: clinicaland pathogenic implications", 123, pp.263~270 (2003)
15. "A clinical staging system for multiplemyeloma Correlation of measured myeloma cell mass with pre-senting clinical features response to treatment", pp.842~54
16. "Criteria for evaluating disease response and progression inpatient with multiple myeloma treated by high-dose therapy andhaemopoietic stem cell transplantation. Myeloma Subcommittee ofthe EBMT. European Group for Blood and Marrow Transplant", 102, pp.1115~1123 (1998)
17. "Osteopontin: a bridge between boneand blood", 134, pp.467~474 (2006)
18. "Bone marrow angiogenesis and progression in multiple myeloma", 87, pp.503~8 (1994)
19. "Serum levels of the angiogenic cytokines basic fibroblast growthfactor (bFGF), vascular endothelial growth factor (VEGF) and hep-atocyte growth factor (HGF) in multiple myeloma", 66, pp.83~88 (2001)
20. "Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma", 89, pp.174~182 (2004)
21. "of serum reference range for free light chains and its clinical usefulness in multiple myeloma", 24, pp.273~278 (2004)
22. "혈청유리형경쇄참고치설정과다발성골수종환자들에서의임상적의의", 24, pp.273~278 (2004)

관련 논문AI추천